FindTrial
Sign In

To study the molecular pathway of colorectal carcinoma, and its association with expression of other markers

Microsatellite instability in colorectal carcinoma, and its association with Programmed Cell Death Ligand 1 (PD-L1) expression - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/066689
Enrollment
30
Registered
2024-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C189- Malignant neoplasm of colon, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed and Histologically confirmed cases of colorectal carcinoma

Exclusion criteria

Exclusion criteria: Patients who have recieved prior chemotherapy/immunotherapy

Design outcomes

Primary

MeasureTime frame
1.Proportion of cases of colorectal carcinoma with deficient mismatch repair (dMMR). 2.Proportion of cases of colorectal carcinoma showing PD-L1 expressionTimepoint: Baseline—

Secondary

MeasureTime frame
1.Association of MSI status and immunohistochemical expression of PD-L1 with clinicopathological parametersTimepoint: Baseline—

Countries

India

Contacts

Public ContactDr Nita Khurana

Maulana Azad Medical College

nitakhurana1@gmail.com9968604289

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026